I Begged My Sister Not to Try Ibogaine. I Never Spoke to Her Again
Summary
Marisa Collins struggled with opioid addiction and sought ibogaine treatment in Utah after stopping methadone. Her sister, Alyce, urged her not to go; the article says ibogaine was not FDA-approved, and the sisters never spoke again after Marisa left for treatment.Key Facts
- Marisa and Alyce were 11 months apart and grew up close with their older sister in a single-parent household.
- Marisa began using opioids around age 21 and later had regular access to pain medication after a serious car accident.
- Marisa tried repeatedly to stop using opioids over more than a decade and later attended a methadone clinic.
- After stopping methadone in late 2011, Marisa experienced severe withdrawal and searched online for another treatment.
- Marisa planned to receive ibogaine, a psychoactive drug, at a private home in Utah from a couple she understood to be a nurse and a paramedic.
- The article says ibogaine treatment was not federally approved by the FDA at the time and remains unapproved.
- Alyce warned Marisa against the treatment, and the sisters never spoke again after Marisa left.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
